Associated Banc Corp Sells 3,626 Shares of Colgate-Palmolive (NYSE:CL)

Associated Banc Corp cut its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 72,718 shares of the company’s stock after selling 3,626 shares during the period. Associated Banc Corp’s holdings in Colgate-Palmolive were worth $6,611,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth $26,000. Centricity Wealth Management LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter worth $32,000. Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive during the fourth quarter worth $32,000. Finally, Wintrust Investments LLC bought a new position in shares of Colgate-Palmolive in the 4th quarter valued at $33,000. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $89.80 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The business has a 50-day moving average price of $89.02 and a two-hundred day moving average price of $94.82. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a market cap of $72.87 billion, a P/E ratio of 25.51, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the company posted $0.87 earnings per share. As a group, analysts anticipate that Colgate-Palmolive will post 3.75 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have recently commented on the company. Royal Bank of Canada reiterated a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Friday. Raymond James reiterated an “outperform” rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. UBS Group dropped their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $101.72.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.